Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b071176d1f0558a78a2a65f85f5f523 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2000-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be1b9fc4f2f5481c5d1a2f1769c91535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b62b9250d84f591363a0fcd6ef6d43bc |
publicationDate |
2000-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2376067-A1 |
titleOfInvention |
Use of paclitaxel and steroid derivatives as aromatase inhibitors for the treatment of cancer |
abstract |
There is provided use of a material selected from (i) microtubule stabilising agent; (ii) microtubule disrupter; (iii) a compound of the formula A-B wherein A is an oxyhydrocarbyl group and B is a cyclic group; and (iv) a compound of the formula C-D wherein C is a sulphamate group and D is a cyclic group, for the manufacture of a medicament for the inhibition of tumour necrosis factor .alpha. (TNF.alpha.) stimulated aromatase activity. |
priorityDate |
1999-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |